Market Overview

32 Stocks Moving In Tuesday's Mid-Day Session

Share:

Gainers

  • SemiLEDs Corporation (NASDAQ: LEDS) shares rose 35.8 percent to $4.55.
  • EVINE Live Inc. (NASDAQ: EVLV) gained 28.8 percent to $1.04. The pay-TV home shopping company was named as a potential acquisition target by TechCrunch. According to the publication, Amazon.com, Inc. (NASDAQ: AMZN) is exploring ways of marketing its products and services to consumers beyond the internet.
  • Sanmina Corp (NASDAQ: SANM) shares surged 19.1 percent to $33.00 as the company reported stronger-than-expected earnings for its second quarter on Monday.
  • Heidrick & Struggles International, Inc. (NASDAQ: HSII) gained 14.9 percent to $37.22 as the company posted upbeat results for its first quarter.
  • Santander Consumer USA Holdings Inc. (NYSE: SC) shares climbed 14 percent to $17.90 following upbeat quarterly earnings.
  • Helix Energy Solutions Group, Inc. (NYSE: HLX) climbed 14 percent to $7.12 following strong quarterly results.
  • Check-Cap Ltd. (NASDAQ: CHEK) gained 13.6 percent to $8.25.
  • Atossa Genetics Inc. (NASDAQ: ATOS) rose 11.8 percent to $3.34. Atossa Genetics disclosed that it has Received positive interim review from the Independent Safety Committee in Phase 1 Topical endoxifen dose escalation study in men.
  • Cadence Design Systems, Inc. (NASDAQ: CDNS) gained 11.6 percent to $40.99 after the company posted upbeat Q1 results and issued a strong Q2 forecast.
  • Genprex, Inc. (NASDAQ: GNPX) climbed 11.2 percent to $4.9363.
  • Mitel Networks Corporation (NASDAQ: MITL) rose 10.5 percent to $11.23 after the company agreed to be acquired by affiliates of Searchlight Capital Partners for $2.0 billion.
  • Systemax Inc. (NYSE: SYX) rose 10.2 percent to $30.86. Sidoti & Co. upgraded Systemax from Neutral to Buy.
  • Orchids Paper Products Company (NYSE: TIS) surged 9.2 percent to $7.13. Orchids Paper Products is expected to report its Q1 financial results on Wednesday, April 25, 2018.
  • New Oriental Education & Technology Group Inc. (NYSE: EDU) rose 8.1 percent to $93.86 after reporting Q3 results.
  • Weatherford International plc (NYSE: WFT) gained 7.3 percent to $2.78 after the company reported a narrower-than-expected quarterly loss.
  • Riot Blockchain, Inc. (NASDAQ: RIOT) shares rose 5.4 percent to $6.90 after declining 1.50 percent on Monday.
  • SAP SE (NYSE: SAP) rose 4.3 percent to $110.52 after the company posted strong quarterly results and raised its outlook for the year.
  • Caterpillar Inc. (NYSE: CAT) rose 3.6 percent to $159.4604 following better-than-expected quarterly results.

Check out these big penny stock gainers and losers

Losers

  • Valeritas Holdings Inc (NASDAQ: VLRX) tumbled 29 percent to $1.81. Valeritas priced its 13.7 million share offering at $1.75 per share.
  • Stepan Company (NYSE: SCL) dropped 14.5 percent to $76.29 as the company posted downbeat Q1 results.
  • Casa Systems, Inc. (NASDAQ: CASA) fell 14 percent to $25.64 after announcing a 7.35 million share common stock offering.
  • Epizyme, Inc. (NASDAQ: EPZM) declined 12.6 percent to $13.37. Epizyme announced Monday after the close that the FDA issued a partial clinical hold on the U.S. enrollment of new patients in tazemetostat clinical trials.
  • Arcadia Biosciences, Inc. (NASDAQ: RKDA) shares fell 12.1 percent to $17.45.
  • BioXcel Therapeutics, Inc. (NASDAQ: BTAI) shares dropped 11.5 percent to $8.00.
  • Foresight Autonomous Holdings Ltd (NASDAQ: FRSX) shares declined 10.5 percent to $3.23.
  • Waters Corporation (NYSE: WAT) dipped 8.6 percent to $191.51 following Q1 results.
  • Inspired Entertainment, Inc. (NASDAQ: INSE) dropped 8.6 percent to $4.80.
  • VirnetX Holding Corp (NYSE: VHC) shares declined 7.6 percent to $2.73.
  • Erin Energy Corporation (NYSE: ERN) shares slipped 7.6 percent to $2.495.
  • 3M Company (NYSE: MMM) dropped 7.4 percent to $200.03 after reporting Q1 results.
  • Zealand Pharma A/S (NASDAQ: ZEAL) fell 6.9 percent to $15.24 after rising 9.80 percent on Monday.
  • Incyte Corporation (NASDAQ: INCY) fell 6.1 percent to $64.00. Lilly and Incyte disclosed that the FDA Advisory Committee recommended approval of baricitinib 2mg, but not 4mg, for the treatment of moderately-to-severely active RAI.

Posted-In: Losers Mid-Day GainersNews Movers & Shakers Intraday Update Markets Movers Trading Ideas

 

Related Articles (AMZN + ATOS)

View Comments and Join the Discussion!